4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine

**Description:** 4-(2,4-Dimethyl-thiazol-5-Yl)-pyrimidin-2-Ylamine is a synthetic small molecule with the chemical formula C9H10N4S and a molecular weight of approximately 206.27 g/mol[3][5]. It belongs to the class of organic compounds known as trisubstituted thiazoles[4]. This compound is an experimental cyclin-dependent kinase inhibitor—specifically targeting cyclin-dependent kinase 2 (CDK2)[3][4]. CDK inhibitors are being explored for their potential in cancer therapy due to their ability to interfere with cell cycle progression. There are no approved indications or clinical trials beyond preclinical/experimental use for this compound[1][3][4].

Other names

4-(2,4-dimethylthiazol-5-yl)pyrimidin-2-amino4-(dimethylthiazolyl)pyrimidinamine4-(dimethylthiazolyl)-pyrimidinamine